NanoViricides
NNVC
#10475
Rank
NZ$61.43 M
Marketcap
NZ$2.41
Share price
1.43%
Change (1 day)
-6.93%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): NZ-$0.77

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$0.75. In 2025 the company made an earnings per share (EPS) of NZ-$1.07 an increase over its 2024 EPS that were of NZ-$1.19.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.77-28.36%
2025NZ-$1.07-10%
2024NZ-$1.19-5.41%
2023NZ-$1.265.71%
2022NZ-$1.19-13.58%
2021NZ-$1.37-66.11%
2020NZ-$4.051.7%
2019NZ-$3.99-10.98%
2018NZ-$4.48-22.35%
2017NZ-$5.77-10.53%
2016NZ-$6.45375%
2015NZ-$1.36-85.19%
2014NZ-$9.1642.11%
2013NZ-$6.4526.67%
2012NZ-$5.09-6.25%
2011NZ-$5.4314.28%
2010NZ-$4.75100%
2009NZ-$2.38-0%
2008NZ-$2.38-33.33%
2007NZ-$3.56-0%
2006NZ-$3.564445.07%
2005NZ-$0.07839

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ$12.59-1,786.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.07-912.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.04-909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.59-983.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ-$0.92 22.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$2.94 293.18%๐Ÿ‡บ๐Ÿ‡ธ USA